On 2 May 2016 TEXCELL of France signed a contract for the acquisition of Germany’s Vivo Science GmbH, a GLP/GMP-compliant laboratory specialized in toxicology, immunology and virology in vivo studies.

Texcell, supplier of services in viral security and immunology, is buying Vivo Science, a German company that provides services to the pharmaceutical industry (CRO) and has specialized over the last 15 years in immunogenicity, immunotoxicology and virology in vivo assays. The acquisition is part of Texcell‘s aim of expanding its portfolio of services in the areas of preclinical and clinical research.